H. Lee Moffitt Cancer Center & Research Institute

Research facility


Location: Tampa, FL, United States (USA) (US) US

ISNI: 0000000098915233

ROR: https://ror.org/01xf75524

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Systemic Markers of Inflammation in Neuroendocrine Tumors (NETs) and Outcomes with Everolimus: A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials (2018) Chan DL, Yao JC, Carnaghi C, Buzzoni R, Herbst F, Ridolfi A, Strosberg J, et al. Conference contribution Identification of nine new susceptibility loci for endometrial cancer (2018) O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, et al. Journal article Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, et al. Journal article Myocarditis in Patients Treated With Immune Checkpoint Inhibitors (2018) Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling L, Sullivan RJ, et al. Journal article Deacetylase inhibitors: an advance in myeloma therapy? (2017) Laubach JP, San-Miguel JF, Hungria V, Hou J, Moreau P, Lonial S, Lee JH, et al. Journal article, Review article Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann M, et al. Journal article BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer (2017) Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FMGR, et al. Journal article Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4 (2017) Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, et al. Journal article Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma (2017) Zimmer L, Apuri S, Eroglu Z, Kottschade LA, Forschner A, Gutzmer R, Schlaak M, et al. Journal article